At the end of March, the USDA published some guidance that outlined what their regulatory direction for products of gene editing—like products derived using the CRISPR system—would be. That statement spoke very strongly about the importance of encouraging innovation to encourage economic development in rural communities, and to ensure that regulation was not stronger than it needed to be to assure safety.
The approach we see from the USDA is that products developed using CRISPR that could also be developed using traditional breeding methods will not be subject to regulation. There are a few exceptions around plant pest risk, but that's the general approach they're taking.
What that means for companies operating in the U.S. is that they have a clear direction, so they can move forward to commercializing their products with greater certainty.